SLC2A1 and cancer: Under hypoxic conditions, phloretin, a GLUT1 inhibitor that blocks glucose uptake and glycolysis, re-sensitized both types of cancer cells to daunorubicin's anti-cancer activity and apoptosis-inducing effects (34).